Prestige Consumer Healthcare Inc (NYSE:PBH) has been assigned an average recommendation of “Hold” from the ten research firms that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $68.83.
Several analysts have issued reports on PBH shares. TD Securities boosted their price target on Prestige Consumer Healthcare from $90.00 to $97.00 and gave the company a “hold” rating in a report on Friday, July 24th. ValuEngine lowered Prestige Consumer Healthcare from a “sell” rating to a “strong sell” rating in a report on Thursday, July 2nd. Sidoti raised Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $46.00 price objective for the company in a research note on Monday, June 29th. BMO Capital Markets upped their price objective on Prestige Consumer Healthcare from $91.00 to $95.00 and gave the stock a “market perform” rating in a research note on Friday, July 24th. Finally, DA Davidson lowered Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $49.00 to $45.00 in a research note on Friday, August 7th.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Citizens Financial Group Inc RI grew its stake in Prestige Consumer Healthcare by 214.1% in the second quarter. Citizens Financial Group Inc RI now owns 1,495 shares of the company’s stock worth $56,000 after purchasing an additional 1,019 shares in the last quarter. Advisor Group Holdings Inc. bought a new position in Prestige Consumer Healthcare in the first quarter worth approximately $62,000. Skandinaviska Enskilda Banken AB publ bought a new position in Prestige Consumer Healthcare in the second quarter worth approximately $75,000. Paradigm Asset Management Co. LLC bought a new position in Prestige Consumer Healthcare in the second quarter worth approximately $130,000. Finally, Contravisory Investment Management Inc. bought a new position in Prestige Consumer Healthcare in the second quarter worth approximately $156,000.
NYSE:PBH traded down $0.31 during mid-day trading on Monday, hitting $35.80. 263,558 shares of the company traded hands, compared to its average volume of 471,885. The stock’s fifty day moving average price is $36.51 and its 200-day moving average price is $38.06. Prestige Consumer Healthcare has a one year low of $27.40 and a one year high of $46.12. The company has a quick ratio of 1.35, a current ratio of 2.24 and a debt-to-equity ratio of 1.32. The firm has a market cap of $1.80 billion, a price-to-earnings ratio of 11.97, a price-to-earnings-growth ratio of 2.90 and a beta of 0.77.
Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.70 by $0.16. Prestige Consumer Healthcare had a return on equity of 13.81% and a net margin of 15.84%. The business had revenue of $229.40 million during the quarter, compared to analyst estimates of $221.27 million. During the same quarter in the previous year, the company posted $0.65 earnings per share. Prestige Consumer Healthcare’s revenue for the quarter was down 1.2% on a year-over-year basis. Equities analysts predict that Prestige Consumer Healthcare will post 3.15 EPS for the current year.
Prestige Consumer Healthcare Company Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.